Schedule 13G ownership disclosure

Trevi Therapeutics Inc

Security class unavailable · CUSIP: 89532M101

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,541,471
Percent of class
5.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001040197-22-000003
Form type
SC 13G
Filer
MAI Capital Management
CIK
CIK 1040197
Filed
Apr 08, 2022
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub